Multimodal Imaging in a Case of Chronic Sympathetic Ophthalmia.
chronic uveitis
fundus fluorescein angiography (ffa)
granulomatous panuveitis
indocyanine green angiography (icga)
sympathetic ophthalmia
systemic immunosuppressants
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
accepted:
26
07
2023
medline:
30
8
2023
pubmed:
30
8
2023
entrez:
30
8
2023
Statut:
epublish
Résumé
We report a case of chronic sympathetic ophthalmia (SO) in a one-eyed patient who was successfully managed with systemic immunosuppression therapy. A 77-year-old one-eyed female presented with progressive diminution of vision in the left eye (OS) for one month. She had previously undergone a right eye (OD) pars plana vitrectomy elsewhere for exogenous post-operative endophthalmitis (after manual small incision cataract surgery five months ago), following which she developed phthisis. Granulomatous panuveitis and advanced cataract were noted in the OS. Findings on multimodal imaging, including spectral domain optical coherence tomography (SD-OCT), fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and B-scan ultrasonography, were consistent with those of chronic SO. Promptly, oral steroids and systemic immunosuppressants were initiated under the supervision of a rheumatologist. At the three-week follow-up, complete resolution of clinical signs was observed on multimodal imaging. Chronic SO may present with ambiguous clinical signs, leading to a diagnostic dilemma. This may cause a delay in initiating treatment, which can prove to be highly detrimental, especially in one-eyed patients. Multimodal imaging is critical in excluding differential diagnoses and proves to be indispensable in the timely management of this sight-threatening condition.
Identifiants
pubmed: 37644926
doi: 10.7759/cureus.42645
pmc: PMC10462382
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e42645Informations de copyright
Copyright © 2023, Chaturvedi et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ocul Immunol Inflamm. 2017 Apr;25(2):152-159
pubmed: 27960610
Arch Ophthalmol. 1978 Feb;96(2):263-7
pubmed: 629673
Int Ophthalmol Clin. 2012 Fall;52(4):173-81
pubmed: 22954939
JAMA Ophthalmol. 2014 Oct;132(10):1220
pubmed: 25171189
Arq Bras Oftalmol. 2008 Nov-Dec;71(6):886-9
pubmed: 19169528
BMC Ophthalmol. 2012 Aug 13;12:40
pubmed: 22889440
Ophthalmology. 2002 Aug;109(8):1527-31
pubmed: 12153806
Int Ophthalmol. 2011 Apr;31(2):105-10
pubmed: 21331811
Graefes Arch Clin Exp Ophthalmol. 1998 Aug;236(8):635-8
pubmed: 9717662